Q&A: George Church on Genomics of Cognitive Enhancement
Bill of Health
JUNE 12, 2024
The practicality I’ve noticed over the years is that no matter what we aim at, there’s the very severe, shorter-term FDA trial. In 2004 this was chip synthesis of pathogen DNA. GC: It has piqued my interest for many years. How does your lab handle ethical issues that might arise? In 2014 CRISPR gene drives.
240 
Let's personalize your content